The current study show the potent anti-cancer activity of ATA on HER2-overexpressing breast cancer cells and explore its in vivo therapeutic potential in a mouse xenograft model of HER2-amplified breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.